0 Comments
0 Shares
231 Views
0 Reviews
Search
Discover new people, create new connections and make new friends
-
Please log in to like, share and comment!
-
Imfinzi 500mg Injection - a targeted immunotherapy for advanced cancer treatmentIt is an immunotherapy medication used to treat certain cancer types like non-small cell lung cancer, liver and biliary tract cancer. Imfinzi 500mg Injection contain an active ingredient called durvalumab that works to block PD-L1 protein so that immune system gets activated to kill cancer cells. Uses It can treat- Lung cancer(non small cell lung cancer/small cell lung cancer)...0 Comments 0 Shares 470 Views 0 Reviews
-
Lenvatinib Mesylate Capsules Market – Targeted Kinase Inhibition Expanding Cancer Treatment OptionsMarket Overview The Lenvatinib Mesylate capsules market is expanding as this multi-targeted kinase inhibitor gains broader use in treating thyroid, liver, kidney, and endometrial cancers. By blocking multiple growth signaling pathways, Lenvatinib helps slow tumor progression in patients with advanced or treatment-resistant malignancies. Rising cancer incidence, expanding regulatory approvals,...0 Comments 0 Shares 356 Views 0 Reviews
-
Liquid Biopsy Market Role in Personalized and Targeted Cancer Treatment 2031The Liquid Biopsy Market is gaining importance in treatment monitoring. Repeated blood-based testing can potentially provide information about changes in tumor biology without requiring repeated invasive tissue procedures. The Liquid Biopsy Market was estimated at US$ 4.57 billion in 2021 and is expected to reach US$ 12.69 million by 2031, registering an estimated CAGR of 11.2% through 2031....0 Comments 0 Shares 194 Views 0 Reviews
-
US Metastatic Cancer Treatment Market Trends 2034: Advances in Targeted Therapies and ImmunotherapyUS Metastatic Cancer Treatment Market expansion is driven by the growing use of immunotherapy and targeted medicines. Treatment options are increasingly selected according to cancer type, molecular biomarkers, previous therapies, and individual patient characteristics. The Metastatic Cancer Treatment Market was valued at US$ 66.15 billion in 2025 and is projected to reach US$ 158.86 billion by...0 Comments 0 Shares 123 Views 0 Reviews
-
Epidermal Growth Factor Receptor Inhibitor Market Growth Drivers and Investment OpportunitiesThe global Epidermal Growth Factor Receptor (EGFR) inhibitor industry is witnessing substantial momentum due to the increasing prevalence of cancer, growing adoption of targeted therapies, and advancements in precision medicine. The Epidermal Growth Factor Receptor Inhibitor Market size is expected to reach US$ 32.14 Billion by 2034 from US$ 15.92 Billion in 2025. The market is estimated to...0 Comments 0 Shares 2K Views 0 Reviews
-
HDAC Inhibitor Market Segmentation Analysis by Indication and End UserThe global HDAC inhibitor market is gaining significant momentum as the healthcare industry continues to advance targeted therapies for cancer and other complex diseases. Histone deacetylase (HDAC) inhibitors are a class of compounds that regulate gene expression by altering chromatin structure, making them valuable in the treatment of various malignancies and epigenetic disorders. The...0 Comments 0 Shares 2K Views 0 Reviews
-
Regional Growth Prospects for the Ovarian Cancer Drugs MarketThe Ovarian Cancer Drugs Market is evolving as the need for effective cancer treatments increases worldwide. Valued at USD 3.4 billion in 2022, the Ovarian Cancer Drugs Market is projected to reach USD 5.7 billion by 2030, expanding at a CAGR of 6.6% from 2023 to 2030. Growing ovarian cancer incidence, advances in targeted medicines, and the development of innovative therapies are supporting...0 Comments 0 Shares 839 Views 0 Reviews
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek